MiWear is a project funded by the European Innovation Council and led by QUANTUNE TECHNOLOGIES GmbH alongside a consortium of European experts, pioneering the development of a wearable device that promises to redefine the way Metabolic Syndrome and its related conditions are monitored.
MiWear is a bastion of European innovation and represents a hopeful vision for a future where personalized healthcare strategies become a part of everyday life. Through collaboration, cutting-edge technology, and a commitment to health advancement, the MiWear project is on a mission to empower individuals and healthcare providers alike to monitor and manage health.
To revolutionize healthcare by pioneering the use of wearable technology for non-invasive, precise monitoring of metabolic health, empowering individuals to proactively manage their well-being.
To develop and exploit the MiWear device, a groundbreaking innovation in healthcare that utilizes mid-infrared spectroscopy for the real-time, non-invasive monitoring of biomarkers related to metabolic syndrome.
We are committed to innovation, integrity, and collaboration, with a focus on empowering individuals and striving for excellence in healthcare technology. We are dedicated to ethical practices and providing cutting-edge solutions to enhance health management and improve lives.
The MiWear project places health monitoring directly in the hands of individuals, empowering them with the tools and information needed to actively participate in their own health management. This shift not only promotes a deeper understanding of personal health but also encourages a proactive approach to wellness and disease prevention.
By facilitating the non-invasive monitoring of key biomarkers related to metabolic syndrome, MiWear plays a crucial role in the early identification of risk factors, contributing to the prevention of chronic diseases. This capability enables individuals to make timely lifestyle adjustments, significantly lowering the risk of developing serious health conditions.
MiWear will enhance the early detection of health alterations, offering a significant advantage in the timely intervention and management of potential health issues. This early awareness can lead to more effective treatments, reducing the severity of diseases and improving overall health outcomes.
The MiWear project is set to transform healthcare by providing a cost-effective, efficient, and patient-centered approach to disease monitoring and management. Its introduction will alleviate the burden on healthcare systems through reduced hospital visits, lower healthcare costs, and improved patient management strategies.
MiWear is at the forefront of innovation in the wearable tech industry, setting new benchmarks for functionality, accuracy, and user-friendliness. Its success will drive further research and development in wearable technologies, spurring advancements that could redefine health and fitness monitoring.
By integrating cutting-edge technology with health monitoring, MiWear is poised to revolutionize the wellness industry. Its focus on preventive health and personalized data analytics aligns perfectly with the industry's shift towards customized wellness solutions, offering new opportunities for businesses to develop services and products tailored to individual health needs and preferences.
Wearable medical technology is transforming healthcare beyond clinical outcomes. Its success increasingly depends on the patient experience—comfort, usability, and satisfaction all shape how patients engage
We are delighted to introduce a new chapter in our MiWear interview series, where we highlight the people driving innovation across the project. In this
Metabolic syndrome (MetS) is a metabolic disorder that contributes to thrombosis and chronic inflammation, thereby increasing the risk of cardiovascular disease and type 2 diabetes.
We are delighted to introduce the first chapter in our new MiWear interview series, where we highlight the people driving innovation across the project. In
Glucose monitoring is a cornerstone of diabetes care. The 4T program – Teamwork, Targets, Technology, and Tight Control – offers a roadmap for improving outcomes
The report “Evolving Data-Driven Regulation” by a European strategic advisory group on Big Data has outlined the need for medicines regulation to adapt as healthcare
Introducing the Innovators Behind MiWear
